Mourad Tighiouart

From MaRDI portal
Person:454780

Available identifiers

zbMath Open tighiouart.mouradMaRDI QIDQ454780

List of research outcomes





PublicationDate of PublicationType
Combining cytotoxic agents with continuous dose levels in seamless phase I--II clinical trials2024-11-27Paper
Two-stage design for phase I--II cancer clinical trials using continuous dose combinations of cytotoxic agents2024-11-21Paper
A nonparametric Bayesian method for dose finding in drug combinations cancer trials2024-10-29Paper
On the properties of the toxicity index and its statistical efficiency2024-10-29Paper
A Bayesian seamless phase I–II trial design with two stages for cancer clinical trials with drug combinations2020-11-23Paper
Cancer phase I trial design using drug combinations when a fraction of dose limiting toxicities is attributable to one or more agents2019-07-02Paper
A Bayesian adaptive design in cancer phase I trials using dose combinations in the presence of a baseline covariate2019-03-21Paper
Dose finding with escalation with overdose control (EWOC) in cancer clinical trials2016-01-05Paper
Escalation with overdose control using ordinal toxicity grades for cancer phase I clinical trials2013-01-09Paper
Number of patients per cohort and sample size considerations using dose escalation with overdose control2013-01-09Paper
Incorporating a patient dichotomous characteristic in cancer phase I clinical trials using escalation with overdose control2012-10-10Paper
Bayesian Estimators for Conditional Hazard Functions2005-04-22Paper
https://portal.mardi4nfdi.de/entity/Q31471992002-09-18Paper
Value of a Boehmian at a point and at infinity1995-05-15Paper

Research outcomes over time

This page was built for person: Mourad Tighiouart